Significantly, by combining Pin1 and CDK4 inhibitors to prevent APC/CCDH1 inactivation, the APC/CCDH1 induces the degradation of Pin1 and other mitotic proteins, forcing the cells into cell cycle arrest and triggering increased anti-tumor immune activity [126]. The gene discussed is APC; the disease is neoplasm.